Literature DB >> 17092395

Changes in ascertainment of Hib and its influence on the estimation of disease incidence in the United Kingdom.

S Ladhani1, M P Slack, P T Heath, M E Ramsay.   

Abstract

Enhanced surveillance for Hib infection, initially covering Wales and five English regions, began in 1990 and in 1995 was extended to the whole of England and Wales. To determine whether changes in the ascertainment of Haemophilus influenzae may have affected estimates of Hib disease incidence, data from January 1990 to December 2003 were analysed. A total of 8887 and 4020 (45%) cases of H. influenzae and Hib respectively were reported. The proportion of isolates that were serotyped increased over time, and therefore reported incidence may have underestimated the true incidence in the early years of the study. Adjusting for this under-ascertainment, the incidence in children aged <5 years declined from a peak of 28.3/100,000 in 1991 to 0.97/100,000 in 1998 and increased to 3.8/100,000 in 2003. Following the implementation of universal vaccination a dramatic decline in the true incidence of invasive Hib disease occurred. The observation of the subsequent resurgence was real but the highest incidence reached was 85% below the corrected incidence in the pre-vaccine era. Continued high-quality surveillance is needed in order to accurately monitor and detect changes in disease incidence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17092395      PMCID: PMC2870625          DOI: 10.1017/S0950268806007382

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  19 in total

1.  Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis.

Authors:  J McVernon; N Andrews; M P E Slack; M E Ramsay
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

2.  Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.

Authors:  C L Trotter; M E Ramsay; M P E Slack
Journal:  Commun Dis Public Health       Date:  2003-04

3.  Haemophilus influenzae type b vaccine--booster campaign.

Authors:  Paul T Heath; Mary E Ramsay
Journal:  BMJ       Date:  2003-05-31

4.  Getting Hib vaccine to those who need it.

Authors:  R Booy
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

5.  Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

Authors:  D P Greenberg; V K Wong; S Partridge; S J Chang; J Jing; B J Howe; J I Ward
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

6.  Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood.

Authors:  P T Heath; R Booy; H Griffiths; E Clutterbuck; H J Azzopardi; M P Slack; J Fogarty; A C Moloney; E R Moxon
Journal:  Clin Infect Dis       Date:  2000-10-25       Impact factor: 9.079

7.  Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.

Authors:  P T Heath; R Booy; H J Azzopardi; M P Slack; J Bowen-Morris; H Griffiths; M E Ramsay; J J Deeks; E R Moxon
Journal:  JAMA       Date:  2000-11-08       Impact factor: 56.272

Review 8.  Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates.

Authors:  H Peltola
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

Review 9.  The UK Hib vaccine experience.

Authors:  P T Heath; J McVernon
Journal:  Arch Dis Child       Date:  2002-06       Impact factor: 3.791

10.  Antibody to Haemophilus influenzae type b after routine and catch-up vaccination.

Authors:  C L Trotter; J McVernon; N J Andrews; M Burrage; M E Ramsay
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

View more
  3 in total

1.  Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

Authors:  Dominic F Kelly; E Richard Moxon; Ly-Mee Yu; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2008-09-10

2.  Invasive Haemophilus influenzae serotype e and f disease, England and Wales.

Authors:  Shamez N Ladhani; Sarah Collins; Anna Vickers; David J Litt; Carina Crawford; Mary E Ramsay; Mary P E Slack
Journal:  Emerg Infect Dis       Date:  2012-05       Impact factor: 6.883

Review 3.  A review of the role of Haemophilus influenzae in community-acquired pneumonia.

Authors:  Mary P E Slack
Journal:  Pneumonia (Nathan)       Date:  2015-12-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.